369 related articles for article (PubMed ID: 32431217)
21. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease.
Joshi RS; Jagdale SS; Bansode SB; Shankar SS; Tellis MB; Pandya VK; Chugh A; Giri AP; Kulkarni MJ
J Biomol Struct Dyn; 2021 Jun; 39(9):3099-3114. PubMed ID: 32329408
[TBL] [Abstract][Full Text] [Related]
22. In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2.
Byadi S; Oblak D; Kassmi Y; Sadik K; Hachim ME; Podlipnik Č; Aboulmouhajir A
J Biomol Struct Dyn; 2023 Apr; 41(7):2900-2910. PubMed ID: 35168469
[TBL] [Abstract][Full Text] [Related]
23. Caffeic acid phenethyl ester: A review on its pharmacological importance, and its association with free radicals, COVID-19, and radiotherapy.
Taysi S; Algburi FS; Taysi ME; Caglayan C
Phytother Res; 2023 Mar; 37(3):1115-1135. PubMed ID: 36562210
[TBL] [Abstract][Full Text] [Related]
24. Withanolides of
Abreu Alves P; Dantas Rocha KA; Bezerra LL; Ayala AP; Vieira Monteiro NK; Pessoa ODL
J Biomol Struct Dyn; 2023; 41(21):12267-12275. PubMed ID: 36690603
[TBL] [Abstract][Full Text] [Related]
25. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
26. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
Goyal B; Goyal D
ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
[TBL] [Abstract][Full Text] [Related]
27. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
Majumder R; Mandal M
J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
[TBL] [Abstract][Full Text] [Related]
28. Fourteen immunomodulatory alkaloids and two prenylated phenylpropanoids with dual therapeutic approach for COVID-19: molecular docking and dynamics studies.
Omar R; Abd El-Salam M; Elsbaey M; Hassan M
J Biomol Struct Dyn; 2024 Mar; 42(5):2298-2315. PubMed ID: 37116054
[TBL] [Abstract][Full Text] [Related]
29. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease.
C S; S DK; Ragunathan V; Tiwari P; A S; P BD
J Biomol Struct Dyn; 2022 Feb; 40(2):585-611. PubMed ID: 32897178
[TBL] [Abstract][Full Text] [Related]
30. A computational study on active constituents of
Shamsi S; Anjum H; Shahbaaz M; Khan MS; Ataya FS; Alamri A; Alhumaydhi FA; Husain FM; Rehman MT; Mohammad T; Islam A; Anjum F; Shamsi A
J Biomol Struct Dyn; 2022 Oct; 40(17):7702-7713. PubMed ID: 33759703
[TBL] [Abstract][Full Text] [Related]
31.
El-Hddad S; Sobhy M; Ayoub A; El-Adl K
J Biomol Struct Dyn; 2023 Nov; 41(19):9267-9281. PubMed ID: 36399002
[TBL] [Abstract][Full Text] [Related]
32. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease.
Joshi T; Joshi T; Pundir H; Sharma P; Mathpal S; Chandra S
J Biomol Struct Dyn; 2021 Oct; 39(17):6728-6746. PubMed ID: 32752947
[TBL] [Abstract][Full Text] [Related]
33. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2
Khan SA; Zia K; Ashraf S; Uddin R; Ul-Haq Z
J Biomol Struct Dyn; 2021 Apr; 39(7):2607-2616. PubMed ID: 32238094
[TBL] [Abstract][Full Text] [Related]
34. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
[TBL] [Abstract][Full Text] [Related]
35.
Chandel V; Tripathi G; Nayar SA; Rathi B; Kumar A; Kumar D
J Biomol Struct Dyn; 2022; 40(19):8850-8865. PubMed ID: 33939590
[TBL] [Abstract][Full Text] [Related]
36.
Kumar R; Kumar R; Tanwar P
J Biomol Struct Dyn; 2022 Oct; 40(16):7394-7407. PubMed ID: 33715592
[TBL] [Abstract][Full Text] [Related]
37. Molecular modeling study of tectoquinone and acteoside from
Kallingal A; Thachan Kundil V; Ayyolath A; Karlapudi AP; Muringayil Joseph T; E JV
J Biomol Struct Dyn; 2022 Mar; 40(4):1764-1775. PubMed ID: 33036548
[TBL] [Abstract][Full Text] [Related]
38. Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2.
Al-Khafaji K; Al-Duhaidahawi D; Taskin Tok T
J Biomol Struct Dyn; 2021 Jun; 39(9):3387-3395. PubMed ID: 32364041
[TBL] [Abstract][Full Text] [Related]
39. Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach.
Mittal L; Kumari A; Srivastava M; Singh M; Asthana S
J Biomol Struct Dyn; 2021 Jul; 39(10):3662-3680. PubMed ID: 32396769
[TBL] [Abstract][Full Text] [Related]
40. Computational studies on the design of NCI natural products as inhibitors to SARS-CoV-2 main protease.
Durgam L; Guruprasad L
J Biomol Struct Dyn; 2023 Jun; 41(9):3741-3751. PubMed ID: 35333147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
